Table 1 Comparison of the patient’s clinical profile in the three cohorts at recruitment
From: Universal clinical Parkinson’s disease axes identify a major influence of neuroinflammation
Cohort | ||||||
|---|---|---|---|---|---|---|
Discovery (N = 876) | Tracking (N = 1725) | PPMI (N=472) | ||||
Mean | Std | Mean | Std | Mean | Std | |
Under medication (fraction) | 0.87 | 0.34 | 0.9 | 0.3 | 0.06 | 0.24 |
UPDRS I | 8.75 | 5.02 | 9.21 | 5.35 | 6 | 4.6 |
UPDRS II | 8.66 | 5.96 | 9.72 | 6.48 | 6.46 | 4.66 |
UPDRS III | 26.46 | 11.3 | 22.85 | 12.3 | 20.74 | 9.72 |
Age (years) | 67.17 | 9.31 | 67.21 | 9.08 | 61.47 | 9.82 |
Age at diagnostic (years) | 65.93 | 9.35 | 65.87 | 9.07 | 61.02 | 9.8 |
Disease duration (years) | 1.24 | 0.94 | 1.34 | 0.9 | 0.76 | 0.57 |
Number of clinical visits | 3.61 | 1.17 | 3.59 | 1.04 | 11.14 | 3.58 |
Male (fraction) | 0.64 | 0.48 | 0.65 | 0.48 | 0.65 | 0.48 |